This "trumpeting" may also partially explain the observed use of more Xience stents per lesion compared to Resolute (1.18Ϯ0.45 vs. 1.15Ϯ0.42, pϭ0.02) in the Resolute All Comers (RAC) trial. The primary cause for secondary stenting in RAC was "to stabilize target lesion" which includes procedural complications including dissection or perforations.
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Comparison in the 5-year Outcome of Pericardium and Polytetrafluoroethylene-Covered Stents for Saphenous Vein Graft Lesions
Conclusions:
The 5 year follow-up data shows no significant differences in the clinical endpoints between the two covered stents, although numerically it was slightly worse in the PCS group. The rates of TLR and TVR are not discouraging in either stents given the complexity of SVG lesions. Considering the complexity of the lesions treated and the absence of no-reflow, covered stents may provide additional protection. Since there are no very long-term follow-up with other stents in SVG, we cannot compare these results with the traditional stents.
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Outcomes of high-risk patients undergoing percutaneous coronary interventions in the ambulatory versus in-hospital setting 
Mount Sinai School of Medicine, New York, NY
Background: In this study, we investigated the safety of ambulatory percutaneous coronary intervention (PCI) in high-risk patients according to age, creatinine, ejection fraction (ACEF) scores. Methods: The ambulatory PCI group consisted of all consecutive PCI with same-day discharges at Mount Sinai Hospital from January 1, 2003 to March 31, 2011 who had follow-up data. The overnight group consisted of all PCI outpatients in 2004 who were then hospitalized for at least one night. Patients were stratified into two groups based on ACEF score: low (Ͻ1.100) and high (Ն1.100). The primary endpoint was a 30-day major adverse cardiac events (MACE: readmission, all-cause death, and myocardial infarction (MI). Results: Out of 4932 patients, 3216 or 65.2% were in the ambulatory group and the rest (1716) were in the control group. The average age was 61.5 years and were no significant differences in baseline characteristics. Overall 30-day MACE occurred in similar frequency in both groups (Table) , in high and low ACEF scores. 
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